Comerica Bank’s Avidity Biosciences RNAM Stock Holding History

Comerica Bank’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$11.4K	Sell	158 -1,177	-88%	-$76K	﹤0.01%	3217
2025 Q3	$58.2K	Buy	1,335 +576	+76%	+$23.3K	﹤0.01%	2778
2025 Q2	$21.6K	Sell	759 -36	-5%	-$1.07K	﹤0.01%	3030
2025 Q1	$23.5K	Buy	795 +230	+41%	+$7.16K	﹤0.01%	2989
2024 Q4	$16.4K	Sell	565 -58	-9%	-$2.42K	﹤0.01%	3079
2024 Q3	$28.6K	Buy	623 +440	+240%	+$19.1K	﹤0.01%	2933
2024 Q2	$7.48K	Buy	+183	New	+$5.25K	﹤0.01%	3223
2023 Q4	–	Sell	-29	Closed	-$185	–	3818
2023 Q3	$185	Buy	+29	New	+$250	﹤0.01%	3763

Other funds holding RNAM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Comerica Bank's RNAM Position: Q4 2025 in Review

Comerica Bank reduced its Avidity Biosciences (RNAM) stake by 88% in Q4 2025, selling an estimated $76K and leaving 158 shares worth $11.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3217.

Comerica Bank first reported a position in RNAM in Q3 2023 and has held it in 8 quarters since. The position peaked at $58.2K in Q3 2025. 343 funds tracked by Wall St. Rank hold RNAM as of Q4 2025.

Comerica Bank held 158 shares of Avidity Biosciences worth $11.4K as of Q4 2025.
Comerica Bank sold 1,177 Avidity Biosciences shares in Q4 2025, an estimated $76K.
Avidity Biosciences made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #3217 holding.
Comerica Bank first reported a position in Avidity Biosciences in Q3 2023 and has held it in 8 quarters since.
Comerica Bank's Avidity Biosciences position peaked at $58.2K in Q3 2025.
343 funds tracked by Wall St. Rank held Avidity Biosciences as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.